Navigation Links
Manchester leads green chemical training push
Date:1/20/2011

The University of Manchester is leading a 3.7m project to train the next generation of biotechnologists to make chemical processes greener.

The 'European biotechnology training network for the support of the chemical manufacturing industries' (BIOTRAINS) programme brings together microbiologists, enzymologists, chemists, engineers and process development experts involved in the training of the next generation of scientists who will develop green manufacturing methods for the chemical industry.

Led by Professor Nick Turner, Director of the Centre of Excellence for Biocatalysis, Biotransformations and Biocatalytic Manufacture (CoEBio3: www.coebio3.org), the four-year project involves eleven partners from academia and industry who will recruit and train research fellows and another six industrial partners who are offering placement training.

Funded by the European Union FP7 programme, the project is expected to make a major contribution to efforts to replace traditional chemical manufacturing reliant on highly toxic chemicals and solvents with so-called 'white biotechnology'.

White biotechnology employs the power of natural biocatalysts and modern manufacturing techniques to deliver safer and less-environmentally damaging industrial methods.

White biotechnology is a term used mainly in Europe for the application of nature's catalysts, such as enzymes and cells, in biotechnology for industrial purposes.

The use of the word 'white' distinguishes it from other biotechnologies such as 'red' (medicinal) and 'green' (plant) biotechnology.

The term covers the manufacturing of chemicals, alternative energy and biomaterials and has the potential to enable economies to become less dependent on fossil fuels.

At a recent project review meeting in Basel Professor Nick Turner said: "We have been fortunate to recruit some of the very best postgraduate students from our the world to participate in BIOTRAINS. The progress that they have made in a relatively short space of time is impressive and bodes well for the future of this training network ."


'/>"/>

Contact: Daniel Cochlin
daniel.cochlin@manchester.ac.uk
44-161-275-8387
University of Manchester
Source:Eurekalert

Related biology news :

1. University of Manchester academics at international conference on geographic chemicals
2. Opportunity leads to promiscuity among squirrels, study finds
3. Social stress leads to atherosclerosis
4. Research provides new leads in the case against drug-resistant biofilms
5. BOEMRE leads study of deepwater communities post-Deepwater Horizon spill
6. OU study on genetics in fruit flies leads to new method for understanding brain function
7. Marine Pied Piper leads Nemo astray
8. Artificially controlling water condensation leads to room-temperature ice
9. Rapid growth in adolescence leads to fewer offspring, UC Riverside biologists find
10. Barrow scientist leads insula research
11. Gene leads to longer shelf life for tomatoes, possibly other fruits
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/18/2017)... Minn. , Jan. 18, 2017 ... technology company that supports the entire spectrum of ... has been another record-breaking year for the organization ... market interest in MedNet,s eClinical products and services. ... the tremendous marketplace success of iMedNet ...
(Date:1/12/2017)... and PUNE, India , January 12, 2017 ... and Forecasts, 2015 - 2022," projects that the global biometric technology market is expected ... from 2016 to 2022. Continue Reading ... ... ...
(Date:1/6/2017)... , Jan. 5, 2017  SomaLogic announced today ... Life Alliance" established by iCarbonX, the ... build a "Global Digital Health Ecosystem that can ... combination of individual,s biological, behavioral and psychological data, ... between the companies, SomaLogic will provide proteomics data ...
Breaking Biology News(10 mins):
(Date:1/19/2017)... , Jan. 19, 2017 /PRNewswire -- WuXi AppTec, ... open-access capability and technology platform, today announced that ... biology focused preclinical drug discovery contract research organization ... become a wholly-owned subsidiary of WuXi, and will ... and providing greater services. The acquisition will further ...
(Date:1/19/2017)... and GAITHERSBURG, Md. , Jan. ... and Altimmune, Inc., a privately-held immunotherapeutics company targeting ... definitive agreement for the merger of PharmAthene and ... include Novartis Venture Fund, HealthCap, Truffle Capital and ... fully-integrated and diversified immunotherapeutics company with four clinical ...
(Date:1/19/2017)... Ca (PRWEB) , ... January 18, 2017 , ... ... events for tech innovators, engineers, and scientists from around the world, was today ... News. The awards program is based entirely on merit and decided upon by ...
(Date:1/19/2017)... BETHESDA, Md. , Jan. 18, 2017  Northwest ... company developing DCVax® personalized immune therapies for operable and ... Marnix Bosch , Chief Technical Officer of NW Bio, ... Thursday, January 19, 2017, at the Hyatt Regency Hotel ... Dr. Bosch will chair the session entitled "New Therapeutic ...
Breaking Biology Technology: